alendronate and ibutamoren mesylate

alendronate has been researched along with ibutamoren mesylate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cerchio, K; Connor, J; Gertz, BJ; Krupa, D; McClung, M; Murphy, MG; Schnitzer, T; Weiss, S	1

Trials

1 trial(s) available for alendronate and ibutamoren mesylate

Article	Year
Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women. The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:3 Topics: Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Double-Blind Method; Drug Therapy, Combination; Female; Human Growth Hormone; Humans; Indoles; Insulin-Like Growth Factor I; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Placebos; Spiro Compounds; Time Factors	2001

Article

Year

Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.

The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:3

Topics: Aged; Alendronate; Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Remodeling; Collagen; Collagen Type I; Double-Blind Method; Drug Therapy, Combination; Female; Human Growth Hormone; Humans; Indoles; Insulin-Like Growth Factor I; Middle Aged; Osteocalcin; Osteoporosis, Postmenopausal; Peptides; Placebos; Spiro Compounds; Time Factors

2001